Podcasts about emerging infections

Erin Laird, ASTHO Director of Emerging Infections, explains how states are taking action against sepsis; Jeffrey Ekoma, ASTHO Senior Director for Government Affairs, tells us how the recently signed continuing resolution affects funding for public health; an ASTHO tool can help upgrade your structured planning; and Alaska is celebrating 100 years of public health. ASTHO Blog Article: State Health Policies Reduce Sepsis Cases ASTHO Web Page: Foundational Planning Readiness Organizational Self-Assessment Alaska Department of Health Web Page Alaska Department of Health Video: 100 Years of Public Health Alaska State Archives Web Page: Serum Run of 1925  

Clinician-researcher Dr. Jack Lambert shares his experience working on emerging infectious diseases and his approach to treating Lyme disease. In this episode we speak with Dr. Jack Lambert, an infectious disease consultant at the Mater Misericordiae University Hospital in Dublin, Ireland, and professor at the University College Dublin School of Medicine. Originally from Scotland, Dr. Lambert completed his medical training in the US and has specialty certifications in adult and pediatric infectious diseases, general medicine, and sexual health. He's founder of the Lyme Resource Centre and serves as an advisory board member to Invisible International. We spoke with Dr. Lambert about his experience working on emerging infections, his approach to treating Lyme disease patients with antibiotics, and what is needed to improve Lyme disease research.www.lymeresourcecentre.comwww.lookingatlyme.cawww.canlyme.comwww.invisible.international

In this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Peter Chin-Hong from the University of California San Francisco to get an update on important emerging infections. They discuss the current outbreak of COVID-19 and trends in the epidemiology of the disease. They also address emerging measles cases and the underlying pathophysiology of the disease. They also discuss the impact of vaccine disinformation on the risk of measles transmissibility. Finally, they address emerging infections such as avian flu, vaccine developments, and address others like respiratory syncytial virus (RSV) and pertussis.0:00 – Introduction1:42 – Status of the current COVID-19 outbreak3:48 – Update on treatments and vaccination for COVID-19 11:53 – Overview of measles and transmissibility15:30 – Measles herd immunity and vaccine disinformation19:50 – Other emerging infections and vaccine developments23:21 – Closing thoughts __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTube InstagramTikTok...

Since the start of 2024, several countries in South America have experienced a rapid increase in cases of dengue, a viral disease transmitted by the aedes aegypti mosquito. According to the Pan American Health Organization (PAHO), this year alone at least 18 countries in the Americas have reported cases, with more than 400 deaths. In Peru, at the end of February, the government declared an emergency in 20 districts, setting up makeshift clinics and sending additional financial and human resources to affected areas. Dr. Andrés (Willy) Lescano, who leads the Emerging Infections and Climate Change Research Unit at Cayetano Heredia University in Lima, Peru and was one of the co-authors of the Lancet Countdown on Health and Climate Change 2022 report on South America, explains why it has been so challenging to control aedes aegypti mosquitoes in the region, the extent to which urbanization, global warming, and the el Niño phenomenon are driving the current outbreaks, and steps that can be taken to better prepare the health sector for future crises associated with a changing climate.

Dr. Ramirez provides evidence for the chilling source of virtually all emerging infectious illnesses--and why Native Americans were protected from them prior to European Contact. For Further Information: eramirez@weimar.edu; DrEddieRamirez.com; twitter.com_EddieRDMD

Host: David DeRose, MD, MPH. Guest: Eddie Ramirez, MD; Director, HealthWise Lifestyle Medicine. Description: Dr. Ramirez provides evidence for the chilling source of virtually all emerging infectious illnesses--and why Native Americans were protected from them prior to European Contact. For Further Information: eramirez@weimar.edu; DrEddieRamirez.com; twitter.com/EddieRDMD

Speaker: Budder Siddiqui, MD Infectious Diseases, Northeast Georgia Medical Center No disclosures Objectives: • To identify the causes of emerging global infections • To discuss ways to prevent future pandemics

Omar Khalid, ASTHO's Director of Workforce Development, explains the expansion of ASTHO's Public Health – Hope, Equity, Resilience, and Opportunity (PH-HERO) initiative; Erin Laird, ASTHO's Director of Emerging Infections, says preventing infections among dialysis patients is an important public health issue; ASTHO has a new report on the Suicide, Overdose, Adverse Childhood Experiences Prevention Capacity Assessment tool; and a new ASTHO blog article explains how to build capacity to address suicide, overdose, and adverse childhood experiences.   ASTHO Webpage: Funding & Collaboration Opportunities  CDC: Making Dialysis Safer For Patients Coalition ASTHO Webinar: Making Dialysis Safer for Patients Coalition ASTHO Webpage: Island Areas Resource ASTHO Webpage: Building Capacity to Navigate the Prevention of Suicide, Overdose, and Adverse Childhood Experiences  

The Omicron booster, latest ATAGI decisions including the Moderna baby dose and Novavax for teens The new variant vaccines, should we mix and match boosters? Forecasting the next wave Host: Dr David Lim | Total time: 29 mins Guest: A/Prof Nigel Crawford, Infectious Diseases Specialist Register for our upcoming FREE WEBCAST! Every second Tuesday | 7:00pm-9:00pm AEST Click here to register now!See omnystudio.com/listener for privacy information.

Chris Smith is joined by Julia Ravey to examine how emerging infections can spread, they look at a new way of managing pain that doesn't involve drugs and explore what can be done in the Metaverse.

Emerging viral infections go under our microscope this week, including the recent surge in monkeypox, the world's largest bird flu outbreak to date, and learning points from Covid-19. Plus, in the news, the biggest bacterium ever seen, brain training - or brain draining - apps, polio circulating in London, and signs we make friends with people who smell like we do! Like this podcast? Please help us by supporting the Naked Scientists

Dr. Ann Marie Kimball  is a physician, epidemiologist and currently holds the roles of Associate Fellow at the international affairs think tank Chatham House, and Vice Chair, COVID 19 task force, at The Rotary Foundation / Rotary International. Previously, Dr. Kimball served as a strategic advisor to the Rockefeller Foundation, supporting the strengthening and development of strategies for Ebola, post-Ebola, and health crisis response, including planning and guiding the formation of a regional disease surveillance network in collaboration with Connecting Organizations for Regional Disease Surveillance (CORDS). Before joining the Rockefeller Foundation, Dr. Kimball served as technical and strategic lead for the Bill and Melinda Gates Foundation surveillance strategy formation. Prior to Gates, Dr. Kimball served as Professor of Epidemiology for the University of Washington (UW), School of Public Health, with adjunct appointments in Medicine (Bioinformatics and Infectious Diseases) and the Jackson School of Foreign Affairs. During her tenure at UW, Dr. Kimball founded and directed the APEC Emerging Infections Network, and led research and training programs in Surveillance and Informatics in Peru and Thailand. Dr. Kimball's research focus on global trade and emerging infections earned her a Fulbright New Century Scholars award and a Guggenheim Scholars award. Dr. Kimball is also the author of Risky Trade: Infectious Diseases in an Era of Global Trade, which was highly reviewed by NEJM, Emerging Infections and Lancet. She has authored numerous scientific publications, and served on numerous Institute of Medicine panels. She is also a fellow in the American College of Preventive Medicine and member of the National Biosurveillance Advisory group (NBAS) from the Centers for Disease Control. Dr. Kimball is a former Epidemic Intelligence Service Officer for the Centers for Disease Control in Atlanta, and has worked and lived in the Yemen Arab Republic, Ivory Coast, and Senegal. She served as Director of National Program Support for Pan American Health Organization, directing the elaboration and implementation of medium term AIDS plans in member countries throughout Latin America and the Caribbean. She also served as Director of HIV/AIDS for Washington State, and the founding Chair of the National Alliance of State and Territorial AIDS Directors (NASTAD) in the United States. She attended on staff at Harborview Medical Center first on HIV/AIDS (10 years), then the International Clinic (7 years) and finally UW/Seattle King County at Harborview Medical Center as an attending at the STD clinic.

Mark is on the road with Black Voters Matter, as they recreate the historic 1961 Freedom Rides and to fight for voting rights and against voter suppression. In today's travels, Mark talks with Tennessee State Senator Brenda Gilmore on what they are doing in the state to protect voting rights, including restoring that right for convicted felons. But before we hear from Mark on the bus, we first get word from the CDC's Director of Preparedness and Emerging Infections, Dr. Henry Walke. He fills us in on the major concerns with the coronavirus variant known as delta, including who is high risk for this highly transmissible strain. Mark also talks with Secretary of Education Miguel Cardona on this week's equity summit and reopening schools in a way that is safe and productive for teachers, students, and parents. Executive Producer: Adell Coleman Producer: Brittany Temple Distributor: DCP Entertainment For additional content: makeitplain.com

What causes new infections, like Covid-19, to emerge in the first place? Why does the same temperature seem to feel colder in the day than it does at night? Why have we locked down the world for Covid-19 when it seems less serious than we first thought? We also talk about the symptoms of long-Covid, and explain how the heart formed back in evolutionary history, with Dr Chris Smith and 567 CapeTalk's Kieno Kammies... Like this podcast? Please help us by supporting the Naked Scientists

What causes new infections, like Covid-19, to emerge in the first place? Why does the same temperature seem to feel colder in the day than it does at night? Why have we locked down the world for Covid-19 when it seems less serious than we first thought? We also talk about the symptoms of long-Covid, and explain how the heart formed back in evolutionary history, with Dr Chris Smith and 567 CapeTalk's Kieno Kammies... Like this podcast? Please help us by supporting the Naked Scientists

Infectious disease physician from Marie Bashir Institute for Emerging Infections and Biosecurity, Professor Lyn Gilbert, says we should wear masks where social distancing isn't possible.

David Pride, MD, PhD discusses the infrastructure that allows UC San Diego to respond to a public health crisis such as COVID-19. He also shares how creating a Center for Emerging Infections would benefit the region and the state. Series: "UC San Diego Foundation Board" [Health and Medicine] [Show ID: 36144]

David Pride, MD, PhD discusses the infrastructure that allows UC San Diego to respond to a public health crisis such as COVID-19. He also shares how creating a Center for Emerging Infections would benefit the region and the state. Series: "UC San Diego Foundation Board" [Health and Medicine] [Show ID: 36144]

David Pride, MD, PhD discusses the infrastructure that allows UC San Diego to respond to a public health crisis such as COVID-19. He also shares how creating a Center for Emerging Infections would benefit the region and the state. Series: "UC San Diego Foundation Board" [Health and Medicine] [Show ID: 36144]

David Pride, MD, PhD discusses the infrastructure that allows UC San Diego to respond to a public health crisis such as COVID-19. He also shares how creating a Center for Emerging Infections would benefit the region and the state. Series: "UC San Diego Foundation Board" [Health and Medicine] [Show ID: 36144]

David Pride, MD, PhD discusses the infrastructure that allows UC San Diego to respond to a public health crisis such as COVID-19. He also shares how creating a Center for Emerging Infections would benefit the region and the state. Series: "UC San Diego Foundation Board" [Health and Medicine] [Show ID: 36144]

David Pride, MD, PhD discusses the infrastructure that allows UC San Diego to respond to a public health crisis such as COVID-19. He also shares how creating a Center for Emerging Infections would benefit the region and the state. Series: "UC San Diego Foundation Board" [Health and Medicine] [Show ID: 36144]

David Pride, MD, PhD discusses the infrastructure that allows UC San Diego to respond to a public health crisis such as COVID-19. He also shares how creating a Center for Emerging Infections would benefit the region and the state. Series: "UC San Diego Foundation Board" [Health and Medicine] [Show ID: 36144]

David Pride, MD, PhD discusses the infrastructure that allows UC San Diego to respond to a public health crisis such as COVID-19. He also shares how creating a Center for Emerging Infections would benefit the region and the state. Series: "UC San Diego Foundation Board" [Health and Medicine] [Show ID: 36144]

Dr Zieve talks with Michael Schmidt, PhD, author of Beyond Antibiotics, about the shift from overprescription of antibiotics to a new focus on balancing our internal flora and maintaining good immune function. Michael A. Schmidt, Ph.D. has spent some 20 years in the field of molecular medicine, metabolic modeling, physiologic monitoring, and pattern recognition related to human performance. He is on the faculty of the University of South Florida College Medicine, where he lectures on molecular medicine, neuroplasticity, metabolic networks, systems theory, and clinical chemistry. Dr. Schmidt collaborates in primary research on human pathogens with the Infectious Disease Research Center at Colorado State University. This work is focused on microbial threats, such as MRSA, Dengue Fever, and others. He is also a Principal Investigator on a series of human performance studies at NASA Ames Research Center. In collaboration with scientists from the Southwest Research Institute, he is currently working to develop some of the early human attended biomedical experiments that will be launched by Virgin Galactic and XCOR, as part of the commercial suborbital space program. Dr. Schmidt is the author of a book on human host defenses, entitled Beyond Antibiotics: Strategies for Living in a World of Emerging Infections and Antibiotic Resistant Bacteria. He is a member of the Society for Neuroscience, the Metabolomics Society, and the Epigenetics Society, and the founder of Sovaris Aerospace. Read more at sovarisaerospace.com. If you cannot see the audio controls, your browser does not support the audio element

On today’s show, I am joined by Dr. David Schwartz, Professor of Pathology at The Medical College of Georgia and a specialist in global maternal health, medical anthropology, and epidemiology. We discuss previous pandemics and their effects on pregnant patients, development of vaccines, and what we know (or think we know) about placental pathology and maternal-fetal transmission with the SARS-Co V-2 virus. Disclaimer: This podcast does not constitute medical advice. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.

The Indian Health Service hosted a COVID-19 call with the media on April 30, 2020. The call featured: * Rear Adm. Michael Toedt, M.D., chief medical officer, Indian Health Service, IHS COVID-19 Response Incident Command System Operations Section Chief * Dr. Henry Walke, Cirector, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention. CDC's COVID-19 Response Deputy Incident Manager for State, Tribal, Local, and Territorial Support Section * Dr. Loretta Christensen, Chief Medical officer, Navajo Area Indian Health Service * Jillian Curtis, Director, Office of Finance and Accounting, Indian Health Service * Lisa Gyorda, Director, Office of Human Resources, Indian Health Service * Capt. Rob Hayes, director, National Supply Service Center, Indian Health Service The full call lasted about an hour. Only the remarks from the IHS and CDC representatives have been uploaded.

Research that came out mere days ago has shown that the coronavirus is disproportionately impacting one gender more than the other - one is catching COVID-19 more frequently and getting sicker than the other. Why? And what can we do about it? Tune in to find out more! The research came out this week from Dr. Nathaniel Hubert at Cornell University who holds a MPH and an MD from Harvard. Currently, he is Senior Advisor for both the CDC’s Division of Preparedness and Emerging Infections. So why does COVID-19 affect one sex more frequently and intensely than the other and what can we do to protect ourselves? Tune in to find out! This episode of The Evolved Caveman Podcast with Dr. John Schinnerer is a challenging interview with Jed Diamond, Ph.D., discussing how we are handling quarantine on Day 23, and why COVID-19 is infecting one gender more than the other and what you can do about it. Jed is a legend in the field of therapy and men's issues having written 17 books and worked in the mental health field for 50 years. He is founder and director of the MenAlive, and author of 17 books including 12 Rules for Good Men and The Irritable Male Syndrome: Understanding and Managing the 4 Key Causes of Depression and Aggression. His research on gender and depression broke new ground in creating a better evaluation system for diagnosing and treating depression in men and women. His work has been featured in major newspapers throughout the United States including the New York Times, and Wall Street Journal. He has been featured on more than 1,000 radio and TV programs including The View, Good Morning Amer­ica, Today Show, CNN-360 with Anderson Cooper, and CNN. He also did a nationally televised special for PBS. Please be sure to rate, share and review to help us spread the word and teach men to evolve past the Man Box culture in which we were all raised.

Dr. Kami Kim, Chief of Infectious Diseases at the University of South Florida College of Medicine, discusses an important subset of emerging infections: sexually transmitted diseases (STIs). She initially reviews the current epidemiology of STIs in the U.S. She differentiates the more common and less common STIs. She goes on to discuss risk factors for sexually transmitted infections. She focuses on Neisseria gonorrhea infections, and discusses epidemiology, drug resistance, and treatment changes. She closes by sharing information on the diverse syndromes associated with Chlamydia trachomatis, including genital ulcer disease, urethritis, and cervicitis, extragenital infections, and pelvic inflammatory disease, and shares general treatment strategies and pitfalls.

Peter Chin-Hong, MD, Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35046]

Peter Chin-Hong, MD, Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35046]

Peter Chin-Hong, MD, Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35046]

Peter Chin-Hong, MD, Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35046]

Peter Chin-Hong, MD, Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35046]

Peter Chin-Hong, MD, Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35046]

Peter Chin-Hong, MD, Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35046]

Peter Chin-Hong, MD, Professor of Medicine, Connie Frank Transplant Center, UCSF. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35046]

In this Global Health World Shared Practice Forum, Dr. Michelle Niescierenko discusses approaches to responding to emerging infections in developing nations. She shares her experience in responding to the Ebola outbreak in 2014, and how her team worked with Liberian hospitals to teach and disseminate best practices on infection control. She describes the successes and challenges in managing the Ebola outbreak, and how she partnered with the CDC, the WHO, and Liberian Ministry of Health to implement a structured response system to manage the spread of the Ebola virus. Following this discussion, participants will be able to: - Describe the origins of Ebola and its spread to surrounding areas - Identify specific challenges in responding to emerging infections in a remote region - Explain how best medical practices in infection control were taught, disseminated and sustained in hospitals throughout Liberia Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children’s Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user.For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu

Dr John Frater, Principal Investigator, Institute for Emerging Infections and Dr Ellie Barnes, Principal Investigator, Institute for Emerging Infections.

Dr John Frater, Principal Investigator, Institute for Emerging Infections and Dr Ellie Barnes, Principal Investigator, Institute for Emerging Infections.

Margaret Parker, MD, MCCM, speaks with the Society of Critical Care Medicine President-Elect, Craig Coopersmith, MD, FCCM, and Jay Varkey, MD, about the Ebola epidemic.

Margaret Parker, MD, MCCM, speaks with the Society of Critical Care Medicine President-Elect, Craig Coopersmith, MD, FCCM, and Jay Varkey, MD, about the Ebola epidemic.

Editor-in-chief Shawn Kennedy and Clinical Managing Editor Karen Roush present the highlights of the January issue of the American Journal of Nursing. A painting on this month's cover depicts a more modern provider in today's changing healthcare landscape than Norman Rockwell's typical portraits of the kindly older family doctor. Our first CE is an original research on employment-based discrimination among foreign-educated nurses. Our second CE defines the principles behind the self-management of urinary and fecal incontinence and what patients need in order to control these conditions on their own. Our annual “Year in Review” recognizes the most significant healthcare stories of the year and assesses the nursing job market. The “Mental Health Matters” column explores public perceptions of the link between mental illness and violence, reviewing the research and how nurses can identify risks. “Emerging Infections” provides updates on Middle East Respiratory Syndrome. We also announce our annual Book of the Year award winners in this issue. And of course there's News, In Our Community, Reflections, Viewpoint, Drug Watch, Art of Nursing, and more.

Editor-in-chief Shawn Kennedy and Clinical Managing Editor Karen Roush present the highlights of the January issue of the American Journal of Nursing. A painting on this month’s cover depicts a more modern provider in today’s changing healthcare landscape than Norman Rockwell’s typical portraits of the kindly older family doctor. Our first CE is an original research on employment-based discrimination among foreign-educated nurses. Our second CE defines the principles behind the self-management of urinary and fecal incontinence and what patients need in order to control these conditions on their own. Our annual “Year in Review” recognizes the most significant healthcare stories of the year and assesses the nursing job market. The “Mental Health Matters” column explores public perceptions of the link between mental illness and violence, reviewing the research and how nurses can identify risks. “Emerging Infections” provides updates on Middle East Respiratory Syndrome. We also announce our annual Book of the Year award winners in this issue. And of course there’s News, In Our Community, Reflections, Viewpoint, Drug Watch, Art of Nursing, and more.

Editor-in-chief Shawn Kennedy and Clinical Managing Editor Karen Roush present the highlights of the November issue of the American Journal of Nursing. A nursing student appears on this month's cover tying in with our original research piece on newly licensed RNs. Our first CE this month is an emergency article on IV access with an accompanying video. The second CE discusses a pilot study on assessing patients for dysemia. An Emerging Infections article explains Coccidioidomycosis or “valley fever.” AJN Reports and Safety Monitor this month both explore obesity-related topics including the political implications of obesity as a “disease,” and equipment concerns when caring for obese patients. In addition, our issue includes News, In Our Community, Reflections, Viewpoint, Drug Watch, Art of Nursing, and more.

Editor-in-chief Shawn Kennedy and Clinical Managing Editor Karen Roush present the highlights of the November issue of the American Journal of Nursing. A nursing student appears on this month’s cover tying in with our original research piece on newly licensed RNs. Our first CE this month is an emergency article on IV access with an accompanying video. The second CE discusses a pilot study on assessing patients for dysemia. An Emerging Infections article explains Coccidioidomycosis or “valley fever.” AJN Reports and Safety Monitor this month both explore obesity-related topics including the political implications of obesity as a “disease,” and equipment concerns when caring for obese patients. In addition, our issue includes News, In Our Community, Reflections, Viewpoint, Drug Watch, Art of Nursing, and more.

With Professor Paul Klenerman Principal Investigator, Institute for Emerging Infections. Paul Klenerman demonstrates the way our immune systems work and discusses the best way to boost our natural defences in an effort to fight infection from Hep C and HIV. Dr Bennett Foddy, Deputy Director, Institute for Science and Ethics, addresses the ethical dilemmas which can arise from the process of clinical trials.

With Professor Paul Klenerman Principal Investigator, Institute for Emerging Infections. Paul Klenerman demonstrates the way our immune systems work and discusses the best way to boost our natural defences in an effort to fight infection from Hep C and HIV. Dr Bennett Foddy, Deputy Director, Institute for Science and Ethics, addresses the ethical dilemmas which can arise from the process of clinical trials.

Professor Angela McLean, Co-Director, Institute for Emerging Infections advises caution, preparation and fast decision-making in anticipation of the threat of a serious pandemic.

Editor-in-chief Shawn Kennedy and clinical managing editor Karen Roush present the highlights of the April issue of the American Journal of Nursing. This month offers two CE features: one an original research piece (“Interactions of People with Disabilities and Nursing Staff During Hospitalization”), and the other a feature on underutilization of emergency contraception. There are also columns on Policy and Politics, Emerging Infections, and evidence-based management of cancer fatigue, plus Art of Nursing, Reflections, “In the News”, and more. You can listen to podcast interviews with the CE feature authors, too.

Editor-in-chief Shawn Kennedy and clinical managing editor Karen Roush present the highlights of the April issue of the American Journal of Nursing. This month offers two CE features: one an original research piece (“Interactions of People with Disabilities and Nursing Staff During Hospitalization”), and the other a feature on underutilization of emergency contraception. There are also columns on Policy and Politics, Emerging Infections, and evidence-based management of cancer fatigue, plus Art of Nursing, Reflections, “In the News”, and more. You can listen to podcast interviews with the CE feature authors, too.

Dr Tao Dong tells us about her collaborations in China on infections such as HIV, flu and Hepatitis B. Due to its population size, China is a major contributor to infectious disease worldwide - large-scale patient cohorts, well-established infrastructure, and government funding also make research more accessible. Dr Tao Dong's research interests include antigen-specific T cell responses in human virus infections and their contribution to the consequences of the disease. Dr Dong is currently collaborating with Chinese hospitals to research human virus infections such as Hepatitis B, influenza, and Hepatitis C/HIV co-infection.

Dr Tao Dong tells us about her collaborations in China on infections such as HIV, flu and Hepatitis B. Due to its population size, China is a major contributor to infectious disease worldwide - large-scale patient cohorts, well-established infrastructure, and government funding also make research more accessible. Dr Tao Dong's research interests include antigen-specific T cell responses in human virus infections and their contribution to the consequences of the disease. Dr Dong is currently collaborating with Chinese hospitals to research human virus infections such as Hepatitis B, influenza, and Hepatitis C/HIV co-infection.